Novel 2,3-disubstituted quinazoline-4(3H)-one molecules derived from amino acid linked sulphonamide as a potent malarial antifolates for DHFR inhibition

Eur J Med Chem. 2017 Mar 31:129:251-265. doi: 10.1016/j.ejmech.2017.02.012. Epub 2017 Feb 13.

Abstract

An optimization of a modified Grimmel's method for N-heterocyclization of Leucine linked sulphonamide leading to 2,3-disustituted-4-quinazolin-(3H)-ones was accomplished. Further, nineteen hybrid quinazolinone motifs (5a-5s) were synthesized by N-heterocyclization reaction under microwave irradiation using TEAA (IL) as green solvent as well as catalyst. The in vitro screening of the hybrid entities against the plasmodium species P. falciparum yielded five antimalarial potent molecules 5g, 5l, 5m, 5n &5p owing comparable activity to the reference drugs. The active scaffolds were further evaluated for enzyme inhibition efficacy against alleged receptor Pf-DHFR computationally as well as in vitro, proving their candidature as lead dihydrofolate reductase inhibitors. The prediction of the ADMET properties of the potent molecules also indicated their good oral bioavailability.

Keywords: Cytotoxicity; Glide; MTT assay; Maestro; Triethylammonium acetate; p-LDH assay.

MeSH terms

  • Amino Acids / chemistry
  • Antimalarials / chemical synthesis*
  • Antimalarials / pharmacology
  • Biological Availability
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / pharmacology
  • Folic Acid Antagonists / chemical synthesis*
  • Folic Acid Antagonists / pharmacology
  • Plasmodium falciparum / drug effects
  • Quinazolines / chemical synthesis
  • Quinazolines / pharmacology*
  • Sulfonamides / chemistry
  • Tetrahydrofolate Dehydrogenase

Substances

  • Amino Acids
  • Antimalarials
  • Enzyme Inhibitors
  • Folic Acid Antagonists
  • Quinazolines
  • Sulfonamides
  • Tetrahydrofolate Dehydrogenase